Skip to main content
. 2020 Aug 14;26(30):4442–4452. doi: 10.3748/wjg.v26.i30.4442

Table 1.

Demographic, clinical, laboratory, and procedural variables of patients (1)

Variable n mean ± SD Median (IQR) Min Max
Age (yr) 582 60.1 ± 11.4 60 (53, 67) 23 87
Number of TACE 582 2.5 ± 2.2 2 (1, 3) 1 15
Dose of Lipiodol (mL) 582 4.7 ± 6.8 3 (0, 6) 0 30

TACE: Transarterial hepatic chemoembolization; IQR: Interquartile range.